52
Views
6
CrossRef citations to date
0
Altmetric
Original Article

The cost of treating ribavirin-induced anemia in hepatitis C:the impact of using recombinant human erythropoietin

, , &
Pages 1463-1472 | Accepted 05 Apr 2007, Published online: 17 May 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xin Gao, Jennifer M Stephens, John A Carter, Seema Haider & Vinod K Rustgi. (2012) Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis C. Expert Review of Pharmacoeconomics & Outcomes Research 12:3, pages 335-343.
Read now

Articles from other publishers (5)

Waranya Rattanavipapong, Thunyarat Anothaisintawee & Yot Teerawattananon. (2018) Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis. PLOS ONE 13:2, pages e0193112.
Crossref
Lauren M Hynicka & Emily L Heil. (2013) Anemia Management in Patients with Chronic Viral Hepatitis C. Annals of Pharmacotherapy 47:2, pages 228-236.
Crossref
F. Stickel, B. Helbling, M. Heim, A. Geier, C. Hirschi, B. Terziroli, K. Wehr, A. De Gottardi, F. Negro & T. Gerlach. (2011) Critical review of the use of erythropoietin in the treatment of anaemia during therapy for chronic hepatitis C. Journal of Viral Hepatitis 19:2, pages 77-87.
Crossref
Gaetano Bertino, Annalisa Ardiri, Patrizia Maria Boemi, Giuseppe Stefano Calvagno, Irene Maria Ruggeri, Annalisa Speranza, Maria Milena Santonocito, Dario Ierna, Cosimo Marcello Bruno, Maria Valenti, Roberta Boemi, Simona Naimo & Sergio Neri. (2010) Epoetin alpha improves the response to antiviral treatment in HCV-related chronic hepatitis. European Journal of Clinical Pharmacology 66:10, pages 1055-1063.
Crossref
W. J. Cash, K. Patterson, M. E. Callender & N. I. McDougall. (2010) Adjuvant therapy used in conjunction with combination therapy for chronic hepatitis C improves sustained virus response rates in genotype 1 patients. Journal of Viral Hepatitis 17:4, pages 269-273.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.